Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
AstraZeneca
Chubb
Express Scripts
Novartis
Mallinckrodt
Cerilliant
US Department of Justice
Federal Trade Commission
Citi

Generated: August 21, 2017

DrugPatentWatch Database Preview

REGLAN ODT Drug Profile

« Back to Dashboard

Which patents cover Reglan Odt, and what generic Reglan Odt alternatives are available?

Reglan Odt is a drug marketed by Meda Pharms and is included in one NDA. There are two patents protecting this drug.

This drug has thirteen patent family members in nine countries.

The generic ingredient in REGLAN ODT is metoclopramide hydrochloride. There are twelve drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the metoclopramide hydrochloride profile page.

Summary for Tradename: REGLAN ODT

Patents:2
Applicants:1
NDAs:1
Bulk Api Vendors: see list45
Clinical Trials: see list75
Patent Applications: see list52
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:REGLAN ODT at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Meda Pharms
REGLAN ODT
metoclopramide hydrochloride
TABLET, ORALLY DISINTEGRATING;ORAL021793-001Jun 10, 2005DISCNNoNo► Subscribe► SubscribeY ► Subscribe
Meda Pharms
REGLAN ODT
metoclopramide hydrochloride
TABLET, ORALLY DISINTEGRATING;ORAL021793-002Jun 10, 2005DISCNNoNo► Subscribe► SubscribeY ► Subscribe
Meda Pharms
REGLAN ODT
metoclopramide hydrochloride
TABLET, ORALLY DISINTEGRATING;ORAL021793-001Jun 10, 2005DISCNNoNo► Subscribe► SubscribeY ► Subscribe
Meda Pharms
REGLAN ODT
metoclopramide hydrochloride
TABLET, ORALLY DISINTEGRATING;ORAL021793-002Jun 10, 2005DISCNNoNo► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: REGLAN ODT

Country Document Number Estimated Expiration
World Intellectual Property Organization (WIPO)9846215► Subscribe
Spain2525720► Subscribe
European Patent Office2266538► Subscribe
Australia726336► Subscribe
Portugal2147669► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

AstraZeneca
Moodys
Harvard Business School
Deloitte
Julphar
Citi
McKinsey
Fish and Richardson
Johnson and Johnson
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot